[XENE] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
03-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 1.82%
YoY- -22.67%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 0 16 264 15 16 376 413 -
PBT -3,755 -8,065 -7,742 -7,380 -7,517 -6,004 -7,714 -38.14%
Tax 159 14 -902 -513 -470 542 383 -44.37%
NP -3,755 -8,065 -7,742 -7,380 -7,517 -6,004 -7,714 -38.14%
Tax Rate - - - - - - - -
Total Cost 3,755 8,081 8,006 7,395 7,533 6,380 8,127 -40.26%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 0.00 -50,406.25 -2,932.58 -49,200.00 -46,981.25 -1,596.81 -1,867.80 -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -0.22 -0.45 -0.43 -0.41 -0.42 -0.33 -0.51 -42.93%
EPS Diluted -0.21 -0.45 -0.43 -0.41 -0.42 -0.33 -0.51 -44.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.